• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺特异性抗原动力学的分析研究

An Analytical Study of Prostate-Specific Antigen Dynamics.

作者信息

Esteban Ernesto P, Deliz Giovanni, Rivera-Rodriguez Jaileen, Laureano Stephanie M

机构信息

Physics Department, University of Puerto Rico-Humacao, José E. Aguiar Avenue, Road 908 Km 1.2, Humacao, PR 00791, USA.

Biology Department, University of Puerto Rico-Humacao, José E. Aguiar Avenue, Road 908 Km 1.2, Humacao, PR 00791, USA.

出版信息

Comput Math Methods Med. 2016;2016:3929163. doi: 10.1155/2016/3929163. Epub 2016 Nov 13.

DOI:10.1155/2016/3929163
PMID:27956935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5124482/
Abstract

The purpose of this research is to carry out a quantitative study of prostate-specific antigen dynamics for patients with prostatic diseases, such as benign prostatic hyperplasia (BPH) and localized prostate cancer (LPC). The proposed PSA mathematical model was implemented using clinical data of 218 Japanese patients with histological proven BPH and 147 Japanese patients with LPC (stages T2a and T2b). For prostatic diseases (BPH and LPC) a nonlinear equation was obtained and solved in a close form to predict PSA progression with patients' age. The general solution describes PSA dynamics for patients with both diseases LPC and BPH. Particular solutions allow studying PSA dynamics for patients with BPH or LPC. Analytical solutions have been obtained and solved in a close form to develop nomograms for a better understanding of PSA dynamics in patients with BPH and LPC. This study may be useful to improve the diagnostic and prognosis of prostatic diseases.

摘要

本研究的目的是对患有前列腺疾病(如良性前列腺增生症(BPH)和局限性前列腺癌(LPC))的患者进行前列腺特异性抗原动力学的定量研究。所提出的PSA数学模型是利用218例经组织学证实为BPH的日本患者和147例LPC(T2a和T2b期)的日本患者的临床数据实施的。对于前列腺疾病(BPH和LPC),获得了一个非线性方程并用封闭形式求解,以预测PSA随患者年龄的进展。通解描述了LPC和BPH两种疾病患者的PSA动力学。特解允许研究BPH或LPC患者的PSA动力学。已获得解析解并用封闭形式求解,以绘制列线图,以便更好地理解BPH和LPC患者的PSA动力学。本研究可能有助于改善前列腺疾病的诊断和预后。

相似文献

1
An Analytical Study of Prostate-Specific Antigen Dynamics.前列腺特异性抗原动力学的分析研究
Comput Math Methods Med. 2016;2016:3929163. doi: 10.1155/2016/3929163. Epub 2016 Nov 13.
2
Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer.良性前列腺增生症和前列腺癌患者的血清与尿液前列腺特异性抗原比值
Anticancer Res. 2000 Nov-Dec;20(6D):4995-6.
3
Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer.复合前列腺特异性抗原(PSA)与总PSA在鉴别良性前列腺增生和前列腺癌中的临床价值比较。
Urol Int. 2006;76(1):27-30. doi: 10.1159/000089731.
4
Molecular forms of serum prostate-specific antigen: the clinical usefulness of percent free PSA to discriminate prostate cancer from BPH.血清前列腺特异性抗原的分子形式:游离前列腺特异性抗原百分比在鉴别前列腺癌与良性前列腺增生中的临床应用价值
Hinyokika Kiyo. 1998 Apr;44(4):223-32.
5
[The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].[前列腺特异性抗原在局限性前列腺腺癌诊断中的作用。奈良泌尿肿瘤研究组]
Hinyokika Kiyo. 1996 Oct;42(10):795-804.
6
The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.前列腺体积对前列腺癌和良性前列腺增生患者血清中游离前列腺特异性抗原与总前列腺特异性抗原比值的影响。
Cancer. 1997 Jan 1;79(1):104-9.
7
[Usefulness of PSA density (PSAD) in the differential diagnosis between prostatic adenocarcinoma and benign ++ prostatic hypertrophy].前列腺特异抗原密度(PSAD)在前列腺腺癌与良性前列腺增生鉴别诊断中的应用价值
Arch Ital Urol Androl. 1994 Sep;66(4 Suppl):59-63.
8
Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.未治疗的前列腺癌和良性前列腺增生中前列腺特异性抗原和前列腺酸性磷酸酶的评估。
Scand J Urol Nephrol Suppl. 1991;138:97-103.
9
Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.在患有尿潴留和前列腺良性增生或前列腺腺癌的患者中,组织学前列腺炎的意义。
BJU Int. 2012 Apr;109(8):1194-7. doi: 10.1111/j.1464-410X.2011.10527.x. Epub 2011 Aug 18.
10
Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer.良性前列腺增生症和前列腺癌中的胰岛素样生长因子I(IGF-I)及IGF结合蛋白-3
J Clin Endocrinol Metab. 2001 Feb;86(2):694-9. doi: 10.1210/jcem.86.2.7211.

本文引用的文献

1
Low-grade prostate cancer diverges early from high grade and metastatic disease.低级别前列腺癌早期就与高级别和转移性疾病产生分化。
Cancer Sci. 2014 Aug;105(8):1079-85. doi: 10.1111/cas.12460.
2
Prostate-specific antigen mass and free prostate-specific antigen mass for predicting the prostate volume of korean men with biopsy-proven benign prostatic hyperplasia.用于预测经活检证实为良性前列腺增生的韩国男性前列腺体积的前列腺特异性抗原质量和游离前列腺特异性抗原质量
Korean J Urol. 2013 Sep;54(9):609-14. doi: 10.4111/kju.2013.54.9.609. Epub 2013 Sep 10.
3
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
前列腺特异性抗原速度指南在前列腺癌检测中的实证评估。
J Natl Cancer Inst. 2011 Mar 16;103(6):462-9. doi: 10.1093/jnci/djr028. Epub 2011 Feb 24.
4
Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.血清前列腺特异性抗原与不同大小前列腺癌体积的相关性。
Urology. 2010 Nov;76(5):1072-6. doi: 10.1016/j.urology.2009.11.056. Epub 2010 Sep 16.
5
Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer.
Am J Clin Pathol. 2003 Sep;120(3):386-91. doi: 10.1309/82U1-089X-LQGK-MMN1.
6
Characteristic pattern of human prostatic growth with age.人类前列腺随年龄增长的特征性模式。
Asian J Androl. 2002 Dec;4(4):269-71.
7
Prostate-specific antigen, prostate volume and transition zone volume in Japanese patients with histologically proven benign prostatic hyperplasia.经组织学证实的日本良性前列腺增生患者的前列腺特异性抗原、前列腺体积和移行区体积
Int Urol Nephrol. 2001;33(4):645-8. doi: 10.1023/a:1020539404686.
8
Comparison of T1c versus T2 prostate cancers in Japanese patients undergoing radical prostatectomy.
Int Urol Nephrol. 2002;33(1):73-6. doi: 10.1023/a:1014461105701.
9
Correlation of initial PSA level and biopsy features with PSA-doubling time in early stage prostate cancers in Japanese men.
Eur Urol. 2002 Jan;41(1):47-53. doi: 10.1016/s0302-2838(01)00020-3.
10
A quantitative model for the dynamics of serum prostate-specific antigen as a marker for cancerous growth: an explanation for a medical anomaly.作为癌性生长标志物的血清前列腺特异性抗原动态变化的定量模型:对一种医学异常现象的解释。
Am J Pathol. 2001 Jun;158(6):2195-9. doi: 10.1016/S0002-9440(10)64691-3.